Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.0071 | 0.9 |
mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.9 |
mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.0066 | 0.9 |
mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |